Form 4: Cryoport CFO Exercises Options, Sells Shares for Tax

Cryoport's Chief Financial Officer, Robert Stefanovich, reported exercising stock options and selling shares to cover associated taxes and exercise costs.

Summary

• CFO Robert Stefanovich exercised options to acquire 87,188 shares of common stock at an exercise price of $1.87 per share.
• Sold 38,700 shares of common stock at a weighted average price of $7.7619 per share, with proceeds used to pay the exercise price and withholding taxes.
• Received a grant of 27,413 restricted stock rights, which are contingent rights to receive one share of CYRX common stock, vesting in four equal annual installments beginning March 14, 2027.
• Sold 2,743 shares of common stock at $8 per share to cover taxes due upon the vesting of restricted stock rights.
• Received a grant of 82,240 new stock options with an exercise price of $8.6 per share, vesting 1/48 monthly beginning April 14, 2026, and expiring on March 14, 2033.
• Beneficial ownership of common stock decreased from 294,401 shares to 280,371 shares following all reported transactions.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine set of insider transactions, primarily driven by option exercises and tax obligations, with new grants indicating ongoing executive incentive and commitment to the company.

Positives

• The grant of 27,413 restricted stock rights and 82,240 new stock options indicates continued incentive and alignment of management with shareholder interests for future performance.

Negatives

• A net decrease in direct beneficial ownership of common stock by 14,030 shares (from 294,401 to 280,371) after all transactions, although largely attributable to tax-related sales and option exercise costs.

Future Outlook

This Form 4 filing primarily details insider transactions related to compensation and does not contain forward-looking statements or guidance regarding the company's future performance.

Management Comments

• The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the applicable footnotes to this Form 4.

Industry Context

StockSavvy.ai notes that routine insider transactions like option exercises and tax-related sales are common across industries and typically do not signal a significant shift in company fundamentals or broader industry trends. The grant of new equity awards is a standard practice for executive compensation and retention.

Stakeholder Impact

• Shareholders: The transactions represent a slight net decrease in the CFO's direct common stock holdings, primarily due to tax-related sales, which is a common occurrence and generally not indicative of a change in management's long-term view. The new grants align the CFO's interests with future company performance.

Key Dates

Recommendation

The reported transactions are routine insider activities involving option exercises and tax-related sales, alongside new equity grants. They do not provide strong signals for a 'buy' or 'sell' recommendation, as they are primarily compensation-driven rather than discretionary market-timing moves. Therefore, a 'hold' recommendation is appropriate, maintaining current positions while awaiting more substantive operational or financial news.

Keywords

Cryoport, CYRX, Form 4, Insider Transaction, Stock Options, Restricted Stock, Chief Financial Officer, Robert Stefanovich, Beneficial Ownership